Yalonda Howze - Jan 24, 2023 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role: Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Signature: /s/ Yalonda Howze
Stock symbol: CDAKQ
Transactions as of: Jan 24, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/26/2023, 03:15 PM
Previous filing: Jan 23, 2023
Next filing: Mar 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDAKQ	Stock Option (Right to Buy)	Award	$0	+150K		$0.00	150K	Jan 24, 2023	Common Stock	150K	$0.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of this option shall vest and become exercisable on January 24, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.

Remarks:

Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary